BackY-Mabs Therapeutics Overview

Y-Mabs Therapeutics Current Cash

Track Y-Mabs Therapeutics's current cash ($62M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$62.29M
↓ 19.94% YoYΔ $-15.51M vs prior year quarter

Peer trimmed avg / median

Loading

Y-Mabs Therapeutics Current Cash History

Loading

Y-Mabs Therapeutics vs. peers: Current Cash Comparison

Loading

Y-Mabs Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Y-Mabs Therapeutics (YMAB) FAQ

Y-Mabs Therapeutics (YMAB) currently reports a current cash of $62M as of June 2025. That compares with $78M in the prior-year period — down 19.9% year over year. Use the charts on this page to explore Y-Mabs Therapeutics's current cash history and peer comparisons.

Y-Mabs Therapeutics's current cash decreased from $78M to $62M — a 19.9% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Y-Mabs Therapeutics reported $62M in current cash as of June 2025. That compares with $78M in the prior-year period — down 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $62M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Y-Mabs Therapeutics, and consider following YMAB for alerts when major investors trade the stock.

Y-Mabs Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $62M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing YMAB with unrelated industries.